An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543784.2015.1059421
Reference105 articles.
1. Tolvaptan inhibits ERK-dependent cell proliferation, Cl−secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin
2. Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next‐generation sequencing
3. Cilia and polycystic kidney disease, kith and kin
4. Kidney: polycystic kidney disease
5. Third-Hit Signaling in Renal Cyst Formation
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The association between serum Perilipin-2 and kidney disease progression of patients with autosomal dominant polycystic kidney disease;DAHUDER Medical Journal;2024-01-29
2. Comparative transcriptomics of shear stress treated Pkd1−/− cells and pre-cystic kidneys reveals pathways involved in early polycystic kidney disease;Biomedicine & Pharmacotherapy;2018-12
3. Casein kinase 1ε and 1α as novel players in polycystic kidney disease and mechanistic targets for (R)-roscovitine and (S)-CR8;American Journal of Physiology-Renal Physiology;2018-07-01
4. The Myth of Water and Salt: From Aquaretics to Tenapanor;Journal of Renal Nutrition;2018-03
5. Toll-Like Receptors in the Progression of Autosomal Dominant Polycystic Kidney Disease;Therapeutic Apheresis and Dialysis;2016-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3